BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
10/30/2024 2:58:55 PM | Browse: 55 | Download: 207
 |
Received |
|
2024-09-07 19:16 |
|
Peer-Review Started |
|
2024-09-07 19:16 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2024-09-23 08:29 |
|
Revised |
|
2024-09-24 08:28 |
|
Second Decision |
|
2024-10-10 02:41 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2024-10-10 06:05 |
|
Articles in Press |
|
2024-10-10 06:05 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2024-10-15 00:03 |
|
Typeset the Manuscript |
|
2024-10-18 04:35 |
|
Publish the Manuscript Online |
|
2024-10-30 14:58 |
| ISSN |
1948-9366 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Letter to the Editor |
| Article Title |
Unlocking the diagnostic potential of vascular endothelial growth factor and interleukin-17: Advancing early detection strategies for hepatocellular carcinoma
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Shanmathi Subramanian and Hamrish Kumar Rajakumar |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Hamrish Kumar Rajakumar, Department of General Surgery, Government Medical College, Omandurar Government Estate, 169 Wallahjah Road, Police Quarters, Triplicane, Chennai 600002, Tamil Nādu, India. hamrishkumar2003@gmail.com |
| Key Words |
Hepatocellular carcinoma; Biomarkers; Early detection; Diagnostic accuracy; Treatment strategies; Therapeutic targets |
| Core Tip |
Serum vascular endothelial growth factor (VEGF) and interleukin-17 (IL-17) levels show significant promise as diagnostic biomarkers for primary hepatocellular carcinoma (PHC), suggesting potential improvements in early detection and treatment strategies. Elevated levels of these biomarkers correlate with key pathological features and clinical stages of PHC, highlighting their diagnostic value. However, challenges such as cost and availability may limit their widespread use. Integrating VEGF and IL-17 into clinical practice could refine diagnostic accuracy and inform personalized treatment plans, potentially enhancing patient outcomes through more targeted and effective interventions. |
| Publish Date |
2024-10-30 14:58 |
| Citation |
<p>Subramanian S, Rajakumar HK. Unlocking the diagnostic potential of vascular endothelial growth factor and interleukin-17: Advancing early detection strategies for hepatocellular carcinoma. <i>World J Gastrointest Surg</i> 2024; 16(11): 3639-3642</p> |
| URL |
https://www.wjgnet.com/1948-9366/full/v16/i11/3639.htm |
| DOI |
https://dx.doi.org/10.4240/wjgs.v16.i11.3639 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
